Alpha Cognition (ACOG) Receivables - Net (2025 - 2026)
Alpha Cognition (ACOG) posted quarterly Receivables - Net of $4.2 million for Q4 2025, up 48.86% quarter-over-quarter from $2.8 million in Q3 2025.
Alpha Cognition (ACOG) Receivables - Net (2025 - 2026) Analysis & Trends
Alpha Cognition's Receivables - Net history runs 1 years deep, the most recent figure standing at $4.2 million for Q4 2025.
- In Q4 2025, Receivables - Net changed N/A year-over-year to $4.2 million; the TTM figure through Dec 2025 stood at $4.2 million (changed N/A YoY), while the FY2025 annual figure was $4.2 million, changed N/A from the prior year.
- Receivables - Net for Q4 2025 stood at $4.2 million, up from $2.8 million in the prior quarter.
- The five-year high for Receivables - Net was $4.2 million in Q4 2025, with the low at $422796.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | Alpha Cognition | 205.77 Mn | 164.32 Mn | 5.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.47 Mn |
| Jun 30, 2026 | 5.47 Mn |
| Dec 31, 2025 | 4.24 Mn |
| Dec 31, 2025 | 4.24 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 422,796.00 |
| Mar 31, 2025 | 422,796.00 |